Abbott Laboratories antibody test for the Coronavirus strain COVID-19 “demonstrates excellent analytical performance,” researchers from the University of Washington wrote in the Journal of Clinical Microbiology.
Abbott Laboratories antibody test for the Coronavirus strain COVID-19 “demonstrates excellent analytical performance,” researchers from the University of Washington wrote in the Journal of Clinical Microbiology.
The research comes as diagnostics companies begin to develop and roll out antibody tests for the mass population to know who has the virus so others don’t catch it and spread it in the future. Scientists and companies involved also want to know who has had the disease and whether they have built up immunity.
The independent research, conducted by University of Washington School of Medicine in Seattle found that Abbott’s “SARS-CoV-2 IgG lab-based serology blood test had 99.9% specificity and 100% sensitivity for detecting the IgG antibody in patients 17 days or more after symptoms began,” the company said Friday.
The researchers noted that the data “demonstrate excellent analytical performance of the Abbott SARS-CoV-2 IgG test as well as the limited circulation of the virus in the western United States,” the University of Washington researchers wrote in the journal.
